Culture Essays (2953 words) - Pharmaceuticals Policy, CNX Nifty

2.0 ABOUT THE COMPANY 2.10 Background Ranbaxy Laboratories Limited is one of the largest pharmaceutical company in India, which was incorporated in year 1961. It started by Ranbir Singh and Gurbax Singh, as a distributor for a Japanese Company called Shionogi. The name Ranbaxy comes from the partial names of Ranbir and Gurbax. Bhai Mohan Singh bought the company over from his cousins in 1952, and as a family business, took his son Parvinder Singh in to build the business in 1967. The company went through a significant transformation in its business and scale under his leadership. On a more recent note, in 2008, Parvinder Singh?s sons Malvinder Mohan Singh and Shivinder Mohan Singh sold Ranbaxy to a Japanese Pharmaceutical Giant, Daiichi Sankyo. Operations however, is still divided into two divisions as Daiichi Sankyo, as the parent Company continues its major core business of research and developments of new Patent Products, whilst Ranbaxy, as its generic arm concentrates on the business that they are well versed with, which is the generic drugs (Off-Patents) division. Ranbaxy Malaysia Sdn. Bhd., is a subsidiary of Ranbaxy Laboratories Limited (RLL) India, which hold more than 51% of its shares. Since its incorporation in year 1984, the Company had to overcome many diversities in the industry that contributed in losses in the Company financials in its early years of operations. Although Ranbaxy is marked the largest pharmaceutical Company in India, it is at an infant Start-Up stage Company in Malaysia in 1984. As a pharmaceutical Company, the main source of income is derived from sales of Generic Pharmaceuticals Products and sales of Active Pharmaceutical Ingredients. 2.11 Organizational Structure Ranbaxy has Matrix Structure, as illustrated in Figure 1.1, in which people of the similar skill is pooled together so that they are able work together for a common goal. In Ranbaxy, It is divided into five functional departments which is Customer Service, Human Resource, Finance, Sales and Marketing. 2.12 General Composition Even though Ranbaxy Malaysia is a subsidiary of RLL India, the management in Malaysia consist of Malaysian. There is a total of 109 staff in Ranbaxy Malaysia Sdn Bhd. As a sales organization, sales and marketing staff comprises 83% of the total staff. The breakdown by competencies is as below. Figure 1.2 Staff by Department DEPARTMENTNO. OF STAFF HUMAN RESOURCE2 FINANCE10 SALES82 MARKETING9 CUSTOMER SERVICE5 The breakdown by race is as below. Figure 1.3 Staff By Race DEPARTMENTNO. OF STAFF MALAYS17 INDIANS69 CHINESE23 2.13 Product Ranbaxy deals with sales of Generic Off Patent products and Active Pharmaceutical Ingredients (API) in Malaysia. Its products includes: Figure 1.3 Products Of Ranbaxy Products Anti-Infectives Anti-Depressants Anti-AIDS Gastrointestinals Anti-Virals Anti-Rethrovirals Anti-Histamine Analgesics Tranquillizers Anti-Diabetics Lipid Lowering Agents Anti-Hypertensive Cardiovascular Over The Counter 2.14 Stage Of Business Of Ranbaxy Since its incorporation in year 1984, the Company has to overcome many diversities in the industry that contributed in losses in the Company financials in its early years of Operations. Although Ranbaxy is marked the largest pharmaceutical Company in India, it is at an infant Start-Up stage Company in Malaysia in 1984. As a pharmaceutical Company, the main source of income is derived from sales of Generic Pharmaceuticals Products and sales of Active Pharmaceutical Ingredients. Figure 1.4 Stages Of Business Life Cycle As the Company progressed, they mark a bearable percentage in terms of growth of the Company at about 3-5% profits per annum in years 1990 to year 1994. In 1995, Ranbaxy Malaysia employed its new Managing Director, MR. T. Jeyabalan, who has served the position until today. Throughout his tenure as the MD of Ranbaxy, many transformation has been done to built the Company from a 8.2M Ringgit in revenues in 1997 to 108M Ringgit in the years 2009. Over the years, the growth rate of the Company is very substantially high with year 2005 to 2009 achieving growth of nearly 15% versus the growth of the pharmaceutical industry as a whole, which is recorded at 5.6% per annum. To date, Ranbaxy is at an Established Stage. It is thoroughly believed throughout all the employees in the organization that the greatest contributor in the growth of the organization in attributed to its Managing Director himself, for being a visionary leader and able to adapt and adopt new changes for the growth and the betterment of the Company. The changes made has created a positive culture in the Company and its employees, great contributors in the success of the company. 2.2 CULTURE 2.20 Definition According